Navigation Links
LX4211 for Diabetes Shown to Reduce Fasting and Post-Prandial Blood Sugar in Healthy Subjects
Date:9/13/2011

trointestinal-derived peptide hormone that has also been associated with reducing food intake and has been studied as an anti-obesity agent. These two gastrointestinal peptides (GLP-1 and PYY) are secreted into circulation by neuroendocrine cells (L cells) as part of a natural homeostatic mechanism that senses nutrient transit through the gastrointestinal tract. Such nutrient sensing and related mechanisms are thought to be enhanced as a result of certain types of bariatric surgery for weight loss and control of diabetes.

LX4211 treatment also produced a 50.2 mg/dL adjusted mean decrease from baseline in triglycerides, consistent with the triglyceride reduction observed in the Phase 2a study in type 2 diabetics.  In addition, LX4211, compared to placebo, produced a significant adjusted mean decrease in serum uric acid (1.52 mg/dL from baseline to last study visit, p=0.005). Serum uric acid is an emerging marker for cardiovascular risk and renal disease.  These data, together with a trend of improved blood pressure observed in the Phase 2a study, demonstrate that LX4211 has effects on multiple cardiovascular and metabolic risk factors.  Also of importance in this study was the safety of LX4211, which showed no hypoglycemia and no abdominal pain or diarrhea, consistent with the favorable safety profile associated with dual inhibition of SGLT1 and SGLT2 by LX4211 in previous clinical trials. Enrollment in Lexicon's ongoing Phase 2b study of LX4211 in patients with type 2 diabetes is on schedule, with results anticipated in the first half of 2012.

"We have now observed results from several clinical studies of LX4211 which consistently support the concept of dual SGLT1/SGLT2 inhibition for the treatment of diabetes and indicate a long-term opportunity in diabetes prevention," said Pablo Lapuerta, M.D., senior vice president of clinical development and chief medical officer. "The favorab
'/>"/>

SOURCE Lexicon Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Lexicon Completes Phase 1 Clinical Trial and Initiates Phase 2 Clinical Trial of LX4211 in Patients With Type 2 Diabetes
2. Phase 2 Trial of LX4211 Demonstrates Significant and Rapid Improvements in Multiple Parameters in Type 2 Diabetic Patients
3. Lexicon Presents Data Describing LX4211 Positive Phase 2 Clinical Results and Novel Mechanism of Action for Type 2 Diabetes
4. Lexicon Announces Positive Results from New Clinical Study of LX4211 in Type 2 Diabetes Patients
5. Lexicon Presents LX4211 Mechanism of Action Data at American Diabetes Association Meeting and Announces Commencement of Phase 2b Clinical Trial in Type 2 Diabetes
6. Lexicon Presents LX4211 Clinical Data at European Association for the Study of Diabetes Annual Meeting
7. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
8. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
9. The Heart, Diabetes, And Weight Loss Centers of New York Introduce the New Science of Metabolic Diagnosis and Weight Management
10. Isis Initiates Phase 1 Study of ISIS 325568 Targeting Glucagon Receptor to Treat Type 2 Diabetes
11. Diabetes Research Institute Invention Promotes Growth of Stem Cells into Insulin-Producing Cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... Sept. 18, 2014  ADM Tronics Unlimited, Inc. ... Ph.D. to its corporate Advisory Board for business ... at the Harvard Medical School and Visiting Professor ... received his Masters degree in Electronics Engineering and ... University of Bologna. After spending a year as ...
(Date:9/18/2014)... 2014  A $3 million grant from The Glenn ... Michigan to establish a national center of excellence in ... Aging Research at U-M will focus on exploiting and ... effects of aging and postpone diseases in animal models. ... help develop medications that may help people live longer, ...
(Date:9/18/2014)...  Neurotrope, Inc. (OTCQB: NTRP) today announced the appointment ... the Company,s Board of Directors, effective September 12, 2014. ... the Board of seven members. Dr. Altstiel will also ... and a member of the Audit and Compensation Committees ... Scientific Advisory Board, a position he has held since ...
Breaking Medicine Technology:ADM Tronics Appoints Gianluca DeNovi, Ph.D. To Advisory Board 2ADM Tronics Appoints Gianluca DeNovi, Ph.D. To Advisory Board 3$3 M grant funds Paul F. Glenn Center for Aging Research at the University of Michigan 2$3 M grant funds Paul F. Glenn Center for Aging Research at the University of Michigan 3Larry D. Altstiel, M.D., Ph.D. Joins Neurotrope Board of Directors 2Larry D. Altstiel, M.D., Ph.D. Joins Neurotrope Board of Directors 3Larry D. Altstiel, M.D., Ph.D. Joins Neurotrope Board of Directors 4
... The National Association of Boards of Pharmacy® ... PMP InterConnect is now fully operational, providing state prescription ... reducing prescription drug abuse and doctor shopping. NABP,s PMP ... facilitates the sharing of data between state PMPs, a ...
... RATON and JUPITER, Fla., Aug. 5, 2011 In ... Beach area, South Florida Radiation Oncology announced today that ... that enables a radically different approach to treating cancer ... Varian Medical Systems, was engineered from the ground up ...
Cached Medicine Technology:Interstate PMP Data Sharing through NABP PMP InterConnect Is Now a Reality 2Interstate PMP Data Sharing through NABP PMP InterConnect Is Now a Reality 3South Florida Radiation Oncology on the Forefront of Cancer Treatment with the TrueBeam™ Radiotherapy System from Varian Medical Systems 2South Florida Radiation Oncology on the Forefront of Cancer Treatment with the TrueBeam™ Radiotherapy System from Varian Medical Systems 3
(Date:9/19/2014)... Germany (PRWEB) September 19, 2014 ... that its new ND® Infusion Catheter is ... of Frankfurt. , The study commenced on September 4th, ... The use of the new catheter demonstrated a number ... known as stem cells. “We are at the forefront ...
(Date:9/19/2014)... (PRWEB) September 19, 2014 In ... families find affordable home care options, Seniors Guide ... Agencies” on http://www.HomeCareChoice.com - their ... services in Virginia, North Carolina, Ohio, and Indiana. ... about licensing, costs, services offered, training and education, ...
(Date:9/19/2014)... 2014 One of the major trends ... material, making it useful in different application sectors such ... engineering. , Analysts forecast the Global Bioactive Material ... percent over the period 2013-2018. According to the report, ... drivers in the market. There will be an increased ...
(Date:9/19/2014)... CA (PRWEB) September 19, 2014 AttorneyOne.com, a ... the latest information from the FDA on Potassium Chloride ... Baxter International Inc. recalled one lot of Potassium ... on the shipping cartons. Potassium Chloride, administered intravenously, is used ... recall is based on a labeling error on the shipping ...
(Date:9/19/2014)... Yisrayl Hawkins, Pastor of The House of Yahweh wrote ... protect children. He begins by encouraging the reader not to ... there are many other children, like Michael Brown, who are ... than cancer all over the world and must be stopped ... billion Michaels in the world who were left to themselves ...
Breaking Medicine News(10 mins):Health News:First-in-man procedure utilizes a new method of stem cell delivery 2Health News:First-in-man procedure utilizes a new method of stem cell delivery 3Health News:Seniors Guide Offers Advice on How to Find the Right Home Health Care Agency 2Health News:Bioactive Material Market to Grow at 13.30% CAGR to 2018, Forecasts a New Research Report Available at Sandlerresearch.org 2Health News:Bioactive Material Market to Grow at 13.30% CAGR to 2018, Forecasts a New Research Report Available at Sandlerresearch.org 3Health News:Bioactive Material Market to Grow at 13.30% CAGR to 2018, Forecasts a New Research Report Available at Sandlerresearch.org 4Health News:Baxter Recalls Potassium Chloride Injection: AttorneyOne Monitors and Keeps Consumers Informed 2Health News:Yisrayl Hawkins Says the Michael Brown Scenario Will Continue Without Swift Action in New Post 2
... ... (HLA), the nation,s first interactive health literacy software tool, today announced the 1st Annual ... , ... 7, 2010 -- Health Literacy Innovations (HLI), creators of the Health Literacy ...
... ... View" hits radio on July 6th. , ... Atlanta, GA (PRWEB) July 7, 2010 -- Sponsored by ... Southeast this summer for Ryan Hamner Presents: “Hear the Heart” Summer Tour 2010. ...
... ... and request a free 15-page translation localization report that details areas of improvement. ... Westborough, MA (PRWEB) ... its Localization Quiz at http://www.globalvis.com/freebies/localization-quiz/ . , , , , ,Visitors ...
... 2010 Approximately 10% of low back pain (LBP) ... study published in the August issue of Pain ... of health literacy in patients with chronic lower back ... a person,s disability more than pain intensity or a ...
... Obesity ... creator of the Zone Diet. , ... Boston (Vocus) July 6, 2010 -- Appearing on The Mel Robbins Show , ... bestselling author of The Zone, detailed the underlying causes of America’s obesity crisis and talked ...
... Jackson Surgical Assistants ... experience, has joined the executive team as Medical Director. , ... Alpharetta, GA (July 6, 2010) – Jackson Surgical Assistants (JSA) ... has joined the executive team as Medical Director. Dr. Funk will be responsible for ...
Cached Medicine News:Health News:Health Literacy Innovations Announces 1st Annual Health Literacy Innovator Award — Anonymous Donor Offers Prize Money To Winners 2Health News:Health Literacy Innovations Announces 1st Annual Health Literacy Innovator Award — Anonymous Donor Offers Prize Money To Winners 3Health News:Ryan Hamner's Free Hear The Heart Tour Sweeping The South Four-Time Cancer Survivor, Sings Hope To Others 2Health News:Test your Localization Abilities on globalvis.com 2Health News:Attitudes, beliefs and health literacy impact how patients manage chronic lower-back pain 2Health News:Attitudes, beliefs and health literacy impact how patients manage chronic lower-back pain 3Health News:Attitudes, beliefs and health literacy impact how patients manage chronic lower-back pain 4Health News:Zone Diet Creator Dr. Sears Discusses Obesity Causes and Solutions on Mel Robbins Radio Show 2Health News:Jackson Surgical Assistants Names Dr. Sidney Funk as Medical Director 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: